NEW YORK (GenomeWeb) – Thermo Fisher Scientific today said that it has priced $800 million of senior notes.

The Waltham, Massachusetts-based research tools and lab products giant has priced an offering of $450 million aggregate principal amount of 2.15 percent senior notes due 2018 and $350 million aggregate principal amount of 3.65 percent senior notes due 2025. The issuance of the notes is expected to close on or around Dec. 9, and the firm said the notes will pay interest semi-annually.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.